Miller, Kevin Charles http://orcid.org/0000-0002-5534-5570
Johnson, Patrick Connor
Abramson, Jeremy S.
Soumerai, Jacob D.
Yee, Andrew J.
Branagan, Andrew R.
O’Donnell, Elizabeth K. http://orcid.org/0000-0002-4042-1526
Saucier, Anna
Jacobson, Caron A.
Frigault, Matthew J.
Raje, Noopur S. http://orcid.org/0000-0003-3066-1275
Article History
Received: 24 May 2022
Revised: 30 September 2022
Accepted: 6 October 2022
First Online: 1 November 2022
Competing interests
: KCM reports no conflicts of interest. PCJ reports consulting fees from AstraZeneca. JSA reports consulting fees from Bristol-Myers Squibb, Kite Pharma, Genentech, Genmab, and Regeneron. JDS reports research funding from Beigene, BostonGene, Genentech/Roche, GlaxoSmithKline, Moderna, and TG Therapeutics, and consulting fees from Abbvie, AstraZeneca, Beigene, Biogen, Bristol Myers Squibb, Roche, TG Therapeutics, and Verastem. AJY reports consulting fees from AbbVie, Adaptive Biotechnologies, Amgen, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, Janssen, Karyopharm, Oncopeptides, Regeneron, Sanofi, and Takeda. ARB reports consulting fees from Adaptive Biotechnologies, BeiGene, CSL Behring, Genzyme, Karyopharm, Pharmacyclics, and Sanofi. EKO reports consulting fees from Bristol-Myers Squibb, Janssen, Sanofi, Pfizer, and Takeda. AS reports no conflicts of interest. CAJ reports consulting fees from Bluebird, BMS/Celgene, Daiichi-Sankyo, Epizyme, ImmPACT Bio, Instill Bio, Ipsen, Kite/Gilead, Lonza, Novartis, and research funding from Kite/Gilead and Pfizer. MJF reports consulting fees from Arcellx, Bristol-Myers Squibb, Kite/Gilead, Iovance, and Novartis. NSR reports consulting fees from Bristol-Myers Squibb and Janssen.